Диссертация (1140761), страница 24
Текст из файла (страница 24)
1997. - Vol. 66. - P. 54 - 62.177. Use G., Lutfalla G., Gresser I. Alpha and beta interferons and the receptors andtheir friends and relatives // J. Interferon Cytokine Res. 1995. - Vol. 15. - P. 326.178. Van Zee K. J., Stackpole S.A., Montegur W.J. et al. A human tumor necrosisfactor (TNF) mutant that binds exclusively to the p55 TNF receptor producesToxicity in the baboon // J. Exp. Med. 1994. - Vol. 179.
- P. 1185 - 1191.179. Wang В., Amerio P., Sauder D.N. Role of cytokine in epidermal Langerhanscells migration // J. Leukoc. Biol. 1999. Vol. 66, N 1. - P. 33 - 39.180. Wasniewska M, Corrias A, Salerno M, Lombardo F. et al. Outcomes of childrenwith hashitoxicosis. Horm Res Paediatr. 2012;Vol. 77, N1, P. 36-40.181. Weibel L, Sampaio M, Visentin M, Howell K. et al. Evaluation of methotrexateand corticosteroids for the treatment of localized scleroderma (morphoea) in children// Br J Dermatol. 2006.-Vol.155, N.5, P.1013-1020.182. Zhang M., Tracey K.J. Tumor necrosis factor. In Thopson ed. The Cytokinehanook. 3-rd. San Diego, Calif.: Academic Press, 1998. P.
517 - 548.183. Zulian F, Athreya B, Laxer R, Nelson A et al. Juvenile localized scleroderma:clinical and epidemiological features in 750 children. An international study//Rheumatology (Oxford).2006.Vol.45.N.5.p.614-620.184. Zulian F., Woo P., Athrea B., Laxer R. et al. The Pediatric European Society/American College of Rheumatology/ European League against Rheumatismprovisional classification criteria for juvenile systemic sclerosis // ArthritisRheum.2004.Vol.57.p.203-212..
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
